The success of copyright’s blockbuster initially fueled a surge for the drug industry, nevertheless recent shifts present a murky scenario for those considering a stake. Lower-cost alternatives are eating into profits, read more and persistent legal battles add more difficulty to the landscape. While specific companies could still see gains from